Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia / 감염과화학요법
Infection and Chemotherapy
;
: 267-273, 2016.
Artigo
em Inglês
| WPRIM
| ID: wpr-179931
ABSTRACT
Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of health care-associated infections. Vancomycin remains an acceptable treatment option. There has been a welcome increase in the number of agents available for the treatment of MRSA infection. These drugs have certain differentiating attributes and may offer some advantages over vancomycin, but they also have significant limitations. These agents provide some alternative when no other options are available.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Vancomicina
/
Resistência a Meticilina
/
Bacteriemia
/
Staphylococcus aureus Resistente à Meticilina
Idioma:
Inglês
Revista:
Infection and Chemotherapy
Ano de publicação:
2016
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS